- Fitbit (FIT +0.5%) is partnering with Bristol-Myers Squibb-Pfizer Alliance to develop a way to detect an irregular heart rhythm over time.
- FIT's devices will carry the ability to detect atrial fibrillation after receiving FDA approval.
- Rival Apple's Watch already has this feature.